K-Phama companies are targeting Southeast Asia
By Heo, sung-kyu | translator Hong, Ji Yeon
24.09.27 05:39:52
가나다라
0
Collaborative efforts between the government and organizations…"Building a bridgehead for Southeast Asia market"
Korean pharmaceutical companies target Indonesia to establish a bridgehead for Southeast Asia market entry.
Companies have invested in Indonesia by buidling manufacturing plants. The government and associations are also in support.

According to pharmaceutical companies on September 20th, pharmaceutical companies, the government, and organizations are quickly establishing collaborative partnerships with Indonesia.
Recently, public-private representatives, including KPBMA, Ministry of Food and Drug Safety (MFDS), KIMCo, and 15 Korean pharmaceutical and biotech companies, have visited Jakarta, Indonesia, to seek collaborative business opportunities with Indonesian Food and D
Heo, sung-kyu(lib6983@dailypharm.com)
If you want to see the full article, please JOIN US (click)